We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Plavix Patent Trial Delayed

Law360 (July 22, 2004, 12:00 AM EDT) -- A trial over patent rights to Sanofi-Synthélabo’s best-selling blood-thinning drug Plavix has been delayed until next year, leaving a shadow over the French pharmaceutical company.

A change of judge in the Plavix lawsuit, with U.S. District Judge Sidney Stein taking over earlier this year, has delayed the trial by "three to six months,” Hanspeter Spek, Sanofi's head of pharmaceutical operations, told a press conference.

He said a verdict was not expected "before the first or second quarters of 2005.”

The patent to the drug, Sanofi’s best-selling...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.